Suppresses absorption of ALA. This medication is commonly used for High Cholesterol
Statins can lead to elevated liver enzymes, which may increase the risk of liver damage. Studies suggest that liver injury can be associated with statins and potent antioxidants like alpha lipoic acid with its anti-inflammatory action is associated with improved liver circulation, hepatoprotective, and therapeutic in liver conditions and disease.
Stanković MN, Mladenović D, Ninković M, Ethuričić I, Sobajić S, Jorgačević B, de Luka S, Vukicevic RJ, Radosavljević TS. The effects of α-lipoic acid on liver oxidative stress and free fatty acid composition in methionine-choline deficient diet-induced NAFLD. J Med Food. 2014 Feb;17(2):254-61. De Denus S, Spinler SA, Miller K, et al. Statins and liver toxicity: a meta-analysis. Pharmacotherapy. 2004; 24(5):584-591. Alsheikh-Ali AA, Maddukuri PR, Han H, et al. Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer. Journal of the American College of Cardiology 2007;50:409-18. LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. New England Journal of Medicine 2005;352:1425?]35. J Bustamante 1 , et al. . Alpha-lipoic acid in liver metabolism and disease. Free Radic Biol Med. 1998 Apr;24(6):1023-39.
Alpha Lipoic Acid — 100 mg
Low or depleted magnesium levels are associated with a higher likelihood of several cardiovascular problems, including arrhythmias, where people with low magnesium have been shown to have 2–4 times higher odds of these rhythm disturbances compared with those with normal levels. Low magnesium is also linked to worsening coronary artery disease, progression of heart failure, and development or aggravation of hypertension, driven by disrupted cardiac electrical stability, vascular function, and electrolyte balance. Even mild magnesium depletion may contribute to higher blood pressure over time, adding to the overall cardiovascular burden, especially in individuals with existing heart disease or multiple risk factors.
Inadequate vitamin D undermines calcium absorption and bone remodeling, so chronic deficiency increases the risk of low bone mineral density, osteoporosis, and osteomalacia with bone pain and muscle weakness. Epidemiologic data have linked low 25‑hydroxyvitamin D levels with higher rates of fragility fractures, particularly hip and vertebral fractures in older adults, even after adjusting for age and baseline bone density. Clinically, correcting vitamin D deficiency, together with adequate calcium intake, resistance exercise, and fall‑prevention strategies, has been shown to improve bone mineral density and help reduce fracture risk in at‑risk populations.